The short version
NovoCare Pharmacy (Wegovy) is a manufacturer direct-to-patient channel for the FDA-approved product. As of the September 12, 2026 build, for semaglutide its lowest 12-month all-in total is $4,038 (month-to-month plan, verified), shown as a brand benchmark rather than ranked against compounded plans. Verification status: verified.
The numbers, plan by plan
- Semaglutide (brand, pen, month-to-month plan): $349 per month after an introductory $199 per month for the first 1 month. Status: verified, checked September 4, 2026. Wegovy injection self-pay: $199 per month for qualifying new-patient initial fills, then $349 per month ongoing.
- Semaglutide (oral, oral, month-to-month plan): $149 per month, rising to $299 per month at the highest published dose. Status: verified, checked September 4, 2026. Oral Wegovy self-pay: $149 per month at 1.5 mg; $149 at 4 mg through August 31, 2026 then $199; $299 at 9 mg and 25 mg.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. A consultation fee is billed separately. The medication price rises with dose, so our 12-month total uses the titration model described on the methodology page.
How this pricing structure plays out over a year
The first 1 month costs $199 all-in; from month 2 the recurring cost is $349 a month, so the advertised $199 covers 5% of the first year's spend and the recurring price covers the rest. Because the price rises with dose, roughly nine of the first twelve months are billed at the higher tier on the label's schedule, and every month after that.
Compared with the field
On semaglutide, NovoCare Pharmacy (Wegovy)'s lowest twelve-month total of $4,038 is $2,982 above the lowest (Sunlight, $1,056) and above the median of $2,100 across 13 ranked providers. On the value score it scores 45 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: brand. Named pharmacies: Novo Nordisk-contracted mail-order pharmacy. Commitment: month-to-month. Cancellation: No subscription; order per fill.
Questions to ask NovoCare Pharmacy (Wegovy) before paying
Ask, in writing: What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
FDA-approved semaglutide in a pre-filled pen. Flat self-pay price across doses. First FDA-approved oral GLP-1 for weight management available through the same channel.
What to weigh against it
Self-pay price is well above compounded semaglutide plans. Prescription and clinical care must be arranged separately.
Who should choose NovoCare Pharmacy (Wegovy)
Patients who want FDA-approved semaglutide and can afford manufacturer self-pay pricing. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is NovoCare Pharmacy (Wegovy) legitimate? What we can verify
NovoCare Pharmacy (Wegovy) operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices were verified against its own pages, which is the first test. It names its dispensing pharmacy (Novo Nordisk-contracted mail-order pharmacy), which lets a patient verify the license. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
NovoCare Pharmacy (Wegovy) complaints and reputation
We have not yet analyzed public reviews of NovoCare Pharmacy (Wegovy) for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
Introductory pricing recorded: $199 for the first 1 month of semaglutide. We record introductory prices as data and do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. A consultation fee is billed separately.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping is included; transit is typically one to three days by carrier after the pharmacy fills.
Alternatives to NovoCare Pharmacy (Wegovy)
Alternatives worth comparing: NexLife has the highest value score for semaglutide (91) at $1,428 for twelve months; SnagRx has the lowest twelve-month total ($828, verified).
Update history
December 22, 2025 — Oral Wegovy self-pay: $149 (1.5 mg / 4 mg through 2026-08-31), $299 (9 and 25 mg) (price change; source: NovoCare page; verified 2026-09-04). November 6, 2025 — Wegovy pens, self-pay initial fills: $349 → $199 initial fills, then $349 (price change; source: NovoCare page; verified 2026-09-04). March 10, 2025 — Wegovy pens, self-pay: about $499 → $349 flat (price change; source: Novo Nordisk announcement). Full log on the price history page.
How we verified this
NovoCare's pharmacy and Wegovy pages distinguish the injection ($199 for qualifying initial fills, then $349 ongoing) from the oral tablet ($149 at 1.5 mg and at 4 mg through August 31, 2026, then $199; $299 at 9 and 25 mg). Verified against the provider's own pages on 2026-09-04 (first-party verification pass).